Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 6.49 USD 0.46% Market Closed
Market Cap: 836m USD
Have any thoughts about
Cytek Biosciences Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

-24.4
Current
-22
Median
23.7
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-24.4
=
Enterprise Value
577.6m USD
/
EBIT
-23.6m USD
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-27.8
2-Years Forward
EV/EBIT
-72.1
3-Years Forward
EV/EBIT
154.5

See Also

Discover More